Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F16%3A00092313" target="_blank" >RIV/00216224:14110/16:00092313 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.2147/RRU.S119596" target="_blank" >http://dx.doi.org/10.2147/RRU.S119596</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2147/RRU.S119596" target="_blank" >10.2147/RRU.S119596</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia

Popis výsledku v původním jazyce

Objective: The objective of this study was to assess the effectiveness and safety of convective radiofrequency (RF) water vapor thermal therapy in men with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH); a pilot study design with 2-year follow-up evaluations. Patients and methods: Men aged &gt;=45 years with an International Prostate Symptom Score &gt;=13, a maximum urinary flow rate (Qmax) &lt;=15 mL/s, and prostate volume 20–120 cc were enrolled in a prospective, open-label pilot study using convective RF water vapor energy with the Rezum System. Patients were followed up for 2 years after transurethral thermal treatment at 3 international centers in the Dominican Republic, Czech Republic, and Sweden. The transurethral thermal therapy utilizes radiofrequency to generate wet thermal energy in the form of water vapor injected through a rigid endoscope into the lateral lobes and median lobe as needed.

Název v anglickém jazyce

Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia

Popis výsledku anglicky

Objective: The objective of this study was to assess the effectiveness and safety of convective radiofrequency (RF) water vapor thermal therapy in men with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH); a pilot study design with 2-year follow-up evaluations. Patients and methods: Men aged &gt;=45 years with an International Prostate Symptom Score &gt;=13, a maximum urinary flow rate (Qmax) &lt;=15 mL/s, and prostate volume 20–120 cc were enrolled in a prospective, open-label pilot study using convective RF water vapor energy with the Rezum System. Patients were followed up for 2 years after transurethral thermal treatment at 3 international centers in the Dominican Republic, Czech Republic, and Sweden. The transurethral thermal therapy utilizes radiofrequency to generate wet thermal energy in the form of water vapor injected through a rigid endoscope into the lateral lobes and median lobe as needed.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FE - Ostatní obory vnitřního lékařství

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2016

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Research and Reports in Urology

ISSN

2253-2447

e-ISSN

—

Svazek periodika

8

Číslo periodika v rámci svazku

"neuvedeno"

Stát vydavatele periodika

NZ - Nový Zéland

Počet stran výsledku

10

Strana od-do

207-216

Kód UT WoS článku

000390140300001

EID výsledku v databázi Scopus

—